News

Lifetime co-occurring psychiatric disorders in newly diagnosed adults with attention deficit hyperactivity disorder (ADHD) or/ and autism spectrum disorder (ASD)

Artemios Pehlivanidis, Katerina Papanikolaou, Vasilios Mantas, Eva Kalantzi, Kalliopi Korobili, Lida-Alkisti Xenaki, Georgia Vassiliou and Charalambos Papageorgiou Abstract Background: Co-occurring psychiatric disorders in adults with Attention Deficit Hyperactivity Disorder (ADHD) and/ or Autism Spectrum Disorder (ASD) contribute to the burden of the healthcare and possibly to the delay of diagnosis. Aim of the study was…

Read More

Webinar ADHD & Women

October 2020 = ADHD Awareness Month starts with inviting you to join this webinar Organised by the ADHD in Women project, a partnership between the associations ADHS Deutschland and ADHD, ASC & LD Belgium and ADHD Europe Webinar – Women, ADHD and Hormones Thursday, October 1st at 20:00-21:00 CET Guest speaker, expert psychiatrist Prof. Dr.…

Read More

ADHD as a Risk Factor for Infection With Covid-19

Eugene Merzon (1,2) Iris Manor (2,3), Ann Rotem (3), Tzipporah Schneider (4), Shlomo Vinker (1,2), Avivit Golan Cohen (1,2), Ari Lauden (1), Abraham Weizman (2,3,5) and Ilan Green (1,2) Abstract Background: ADHD limits the ability to comply with Covid-19 prevention recommendations. We hypothesized that ADHD constitutes a risk factor for Covid-19 infection and that pharmacotherapy…

Read More

Video

Lifetime co-occurring psychiatric disorders in newly diagnosed adults with attention deficit hyperactivity disorder (ADHD) or/ and autism spectrum disorder (ASD)


Artemios Pehlivanidis, Katerina Papanikolaou, Vasilios Mantas, Eva Kalantzi, Kalliopi Korobili, Lida-Alkisti Xenaki, Georgia Vassiliou and Charalambos Papageorgiou

Abstract Background:
Co-occurring psychiatric disorders in adults with Attention Deficit Hyperactivity Disorder (ADHD) and/ or Autism Spectrum Disorder (ASD) contribute to the burden of the healthcare and possibly to the delay of diagnosis. Aim of the study was to clinically assess the prevalence and compare lifetime co-occurring psychopathology in a sample of newly diagnosed ADHD and/or ASD adults and discuss the diagnostic challenges they pose.

Methods:
The lifetime prevalence rates of ten of the most frequently co-occurring psychiatric diagnoses was registered in 336 adults of normal intelligence who underwent a thorough clinical evaluation for the diagnosis of ADHD and/or ASD for the first time in their lives. Four study groups were formed: the ADHD (n = 151), the ASD (n = 58), the ADHD+ASD (n = 28) and the nonADHD/nonASD (NN) (n = 88) group.

Results:
At least one co-occurring psychopathology was found in 72.8% of the ADHD group, in 50% of the ASD group, in 72.4% of the ADHD+ASD group and in 76.1% of the NN group (p = 0.004). In all groups the most frequent psychiatric disorder was depressive disorder. The only significant difference regarding the patterns of psychiatric cooccurrence between the ADHD and the nonADHD groups (ASD and NN groups) was found for SUD (p = 0.001). Also, the proportion of subjects with Bipolar Disorder was significantly greater in the NN group as compared to those with ASD (p = 0.025).

Conclusions:
Our results support the high prevalence of co-occurring psychiatric disorders in adults with ADHD and/or ASD with the ASD group presenting the lowest rate. The most marked difference between the ADHD and the nonADHD groups was found for SUD. Moreover, our findings highlight the need for a thorough clinical assessment of all referred patients both in the presence and absence of ADHD and/or ASD.

Link to published article

 


Latest on ADHD